HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE

The heavy chain diseases (HCDs) are rare B-cell malignancies characterized by the production of a monoclonal immunoglobulin heavy chain without an associated light chain. There are three types of HCD, defined by the class of immunoglobulin heavy chain produced: IgA (α-HCD), IgG (γ-HCD), and IgM (μ-H...

Full description

Saved in:
Bibliographic Details
Main Authors: Roberto Ria, Franco Dammacco, Angelo Vacca
Format: Article
Language:English
Published: PAGEPress Publications 2018-01-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://www.mjhid.org/index.php/mjhid/article/view/3169
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846098451798949888
author Roberto Ria
Franco Dammacco
Angelo Vacca
author_facet Roberto Ria
Franco Dammacco
Angelo Vacca
author_sort Roberto Ria
collection DOAJ
description The heavy chain diseases (HCDs) are rare B-cell malignancies characterized by the production of a monoclonal immunoglobulin heavy chain without an associated light chain. There are three types of HCD, defined by the class of immunoglobulin heavy chain produced: IgA (α-HCD), IgG (γ-HCD), and IgM (μ-HCD). Alpha-HCD is the most common and usually occurs as intestinal malabsorption in a young adult from a country of the Mediterranean area. Gamma- and μ-HCDs are more rare and associated to a B-cell non-Hodgkin lymphoma that produces an abnormal Ig heavy chain. These patients may occasionally be diagnosed with a monoclonal gammopathy of undetermined significance (MGUS). Fanconi syndrome, on the other hand, can be primary (inherited) or secondary (acquired). The only exception to this rule is the idiopathic form. Adult acquired Fanconi syndrome can be a rare complication of a monoclonal gammopathy. At diagnosis, most patients have a MGUS or smoldering multiple myeloma, with renal failure and evidence of osteomalacia. During follow-up, patients can develop end-stage renal disease. Chemotherapy provides little benefit on renal function.
format Article
id doaj-art-e88e0b4d14d0413ca0e0e92ec4f48e7c
institution Kabale University
issn 2035-3006
language English
publishDate 2018-01-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-e88e0b4d14d0413ca0e0e92ec4f48e7c2025-01-02T00:38:33ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062018-01-01101e2018011e201801110.4084/mjhid.2018.0111731HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATERoberto Ria0Franco Dammacco1Angelo Vacca2Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine, University of Bari “Aldo Moro” Medical School, Bari, ItalyDepartment of Biomedical Sciences and Human Oncology, Section of Internal Medicine, University of Bari “Aldo Moro” Medical School, Bari, ItalyDepartment of Biomedical Sciences and Human Oncology, Section of Internal Medicine, University of Bari “Aldo Moro” Medical School, Bari, ItalyThe heavy chain diseases (HCDs) are rare B-cell malignancies characterized by the production of a monoclonal immunoglobulin heavy chain without an associated light chain. There are three types of HCD, defined by the class of immunoglobulin heavy chain produced: IgA (α-HCD), IgG (γ-HCD), and IgM (μ-HCD). Alpha-HCD is the most common and usually occurs as intestinal malabsorption in a young adult from a country of the Mediterranean area. Gamma- and μ-HCDs are more rare and associated to a B-cell non-Hodgkin lymphoma that produces an abnormal Ig heavy chain. These patients may occasionally be diagnosed with a monoclonal gammopathy of undetermined significance (MGUS). Fanconi syndrome, on the other hand, can be primary (inherited) or secondary (acquired). The only exception to this rule is the idiopathic form. Adult acquired Fanconi syndrome can be a rare complication of a monoclonal gammopathy. At diagnosis, most patients have a MGUS or smoldering multiple myeloma, with renal failure and evidence of osteomalacia. During follow-up, patients can develop end-stage renal disease. Chemotherapy provides little benefit on renal function.https://www.mjhid.org/index.php/mjhid/article/view/3169B-cell malignancies, Fanconi syndrome, heavy chain disease, monoclonal gammopathy, multiple myeloma
spellingShingle Roberto Ria
Franco Dammacco
Angelo Vacca
HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE
Mediterranean Journal of Hematology and Infectious Diseases
B-cell malignancies, Fanconi syndrome, heavy chain disease, monoclonal gammopathy, multiple myeloma
title HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE
title_full HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE
title_fullStr HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE
title_full_unstemmed HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE
title_short HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE
title_sort heavy chain diseases and myeloma associated fanconi syndrome an update
topic B-cell malignancies, Fanconi syndrome, heavy chain disease, monoclonal gammopathy, multiple myeloma
url https://www.mjhid.org/index.php/mjhid/article/view/3169
work_keys_str_mv AT robertoria heavychaindiseasesandmyelomaassociatedfanconisyndromeanupdate
AT francodammacco heavychaindiseasesandmyelomaassociatedfanconisyndromeanupdate
AT angelovacca heavychaindiseasesandmyelomaassociatedfanconisyndromeanupdate